Key result
Bromocriptine with GDMT restores LVEF from 16% to ~64% after arrest in severe PPCM.
Why the study?
Peripartum cardiomyopathy is an uncommon cause of acute heart failure in late pregnancy or early postpartum, and delayed recognition in resource-constrained hospitals lacking advanced cardiac support or biomarker testing may lead to catastrophic complications.
Case Report (n=1)
No
Peripartum cardiomyopathy can present abruptly as intraoperative pulseless electrical activity cardiac arrest, and timely bedside echocardiography coupled with early guideline-directed heart failure therapy and bromocriptine can achieve complete myocardial recovery even in resource-limited rural hospitals.
Answers are grounded in this paper and cite their sources.
May support bromocriptine in PPCM arrest; hypothesis-generating and requires randomized confirmation.
Background: Peripartum Cardiomyopathy (PPCM) is an uncommon cause of acute heart failure occurring in late pregnancy or early postpartum. In resource-constrained hospitals without advanced cardiac support or biomarker testing, delayed recognition may lead to catastrophic complications. Case Illustration: A 28-year-old primigravida underwent elective cesarean delivery and developed sudden Pulseless Electrical Activity (PEA) five minutes postpartum. Return of spontaneous circulation was achieved after two cycles of cardiopulmonary resuscitation. Post-arrest evaluation revealed severe global Left Ventricular (LV) systolic dysfunction (Left Ventricular Ejection Fraction [LVEF] 16%) with LV dilation (Left Ventricular Internal Diameter at end-diastole [LVIDd] 5.4 cm) and preserved Right Ventricular (RV) systolic function (Tricuspid Annular Plane Systolic Excursion [TAPSE] 2.2 cm). Emergency echocardiography was performed in the Intensive Care Unit (ICU); therefore, comprehensive hemodynamic data were limited. Inferior vena cava size was within normal limits. Hemoglobin decreased modestly (12.2 to 10.6 g/dL), and no evidence of massive hemorrhage or distributive shock was observed. In the absence of biomarker availability, diagnosis was established based on clinical echocardiographic correlation. The patient required short-term norepinephrine (0.1 mcg/kg/min for 12 hours) and dobutamine (5 mcg/kg/min for 48 hours) with gradual down-titration. Guideline-directed medical therapy was initiated after stabilization, including sacubitril–valsartan, spironolactone, bisoprolol, dapagliflozin, diuretics, and bromocriptine (5 mg twice daily for one week). LVEF improved to 34% at day 10 and recovered to 64% at three months. Conclusions: PPCM may present as abrupt intraoperative cardiac arrest even in previously healthy women. Early echocardiography and timely heart failure therapy are critical, particularly in secondary hospitals lacking advanced diagnostic tools.
No takes yet. Share an insight, caveat, or question.
Farid et al. (2026) conducted a case report in Peripartum Cardiomyopathy presenting as intraoperative Pulseless Electrical Activity cardiac arrest (n=1). Guideline-directed medical therapy (sacubitril-valsartan, spironolactone, bisoprolol, dapagliflozin, furosemide) and bromocriptine was evaluated on Left Ventricular Ejection Fraction (LVEF) recovery. Guideline-directed medical therapy plus short-term bromocriptine improved LVEF from 16% to 34% at day 10 and 64% at 3 months in a patient with PPCM and intraoperative cardiac arrest.
Synapse has enriched 10 related papers. Consider them for comparative context: